NOVONIX Limited Dec 2024 Form 6-K: Key Updates & Extraordinary Meeting Insights

Based on the provided section of the financial report, here are the key points extracted:

1. Form Type and Filing: The document is a Form 6-K, which is typically used by foreign companies to report significant information to the SEC.
2. Company Identification:

• Name: NOVONIX Limited
• Commission File Number: 001-41208
• Address: Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.

3. Reporting Period: The report pertains to the month of December 2024.
4. Annual Report Filing:

• The registrant indicated that it will file its annual reports under Form 20-F, while Form 40-F is not applicable.

5. Exhibits Included:

• Exhibit 99.1: Notice of Extraordinary General Meeting of NOVONIX Limited, including Form of Proxy, dated December 23, 2024.
• Exhibit 99.2: Appendix 3B (Proposed issue of securities), dated December 23, 2024.

6. Signatures:

• The report is signed by Dr. John Christopher Burns, the Chief Executive Officer of NOVONIX Limited.
• Date of Signature: December 24, 2024.

Insights:

• The filing of a Form 6-K indicates that NOVONIX Limited is communicating important events or changes that may affect its business, which is crucial for investors.
• The inclusion of an Extraordinary General Meeting notice suggests that there may be significant decisions or changes expected within the company.
• Filing under Form 20-F indicates compliance with international reporting standards, which may enhance transparency for investors.

This summary highlights the essential components of the report and the implications of the disclosed information.